Sulfonamide hydroxamic acids, a novel class of histone deacetylase inhibitors, are antiproliferative against human cancer cells

被引：0
|
作者：
Delorme, D
Lavoie, R
Bouchain, G
Frechette, S
Woo, SH
Abou Khalil, E
Leit, S
Fournel, M
Yan, PT
Trachy-Bourget, MC
Li, ZM
Besterman, J
机构：
[1] Methylgene Inc, Med Chem, Montreal, PQ H4S 2A1, Canada
[2] Methylgene Inc, Biol, Montreal, PQ H4S 2A1, Canada
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 223卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
217-MEDI
引用
收藏
页码：B135 / B135
页数：1
相关论文
共 50 条
  • [31] Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells
    Baradari, Viola
    Huether, Alexander
    Hoepfner, Michael
    Schuppan, Detlef
    Scheruebl, Hans
    ENDOCRINE-RELATED CANCER, 2006, 13 (04) : 1237 - 1250
  • [32] Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
    Danqi Chen
    Aijun Shen
    Guanghua Fang
    Hongchun Liu
    Minmin Zhang
    Shuai Tang
    Bing Xiong
    Lanping Ma
    Meiyu Geng
    Jingkang Shen
    ActaPharmaceuticaSinicaB, 2016, 6 (01) : 93 - 99
  • [33] Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
    Chen, Danqi
    Shen, Aijun
    Fang, Guanghua
    Liu, Hongchun
    Zhang, Minmin
    Tang, Shuai
    Xiong, Bing
    Ma, Lanping
    Geng, Meiyu
    Shen, Jingkang
    ACTA PHARMACEUTICA SINICA B, 2016, 6 (01) : 93 - 99
  • [34] Histone Deacetylase Inhibitors: Novel Agents in Cancer Treatment
    Glass, Erica
    Viale, Pamela Hallquist
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (01) : 34 - 40
  • [35] Novel histone deacetylase inhibitors in the treatment of thyroid cancer
    Mitsiades, CS
    Poulaki, V
    McMullan, C
    Negri, J
    Fanourakis, G
    Goudopoulou, A
    Richon, VM
    Marks, PA
    Mitsiades, N
    CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3958 - 3965
  • [36] Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors
    Kortenhorst, Madeleine S. Q.
    Wissing, Michel D.
    Rodriguez, Ronald
    Kachhap, Sushant K.
    Jans, Judith J. M.
    Van der Groep, Petra
    Verheul, Henk M. W.
    Gupta, Anuj
    Aiyetan, Paul O.
    van der Wall, Elsken
    Carducci, Michael A.
    Van Diest, Paul J.
    Marchionni, Luigi
    EPIGENETICS, 2013, 8 (09) : 907 - 920
  • [37] Histone deacetylase inhibitors for the treatment of cancer stem cells
    Dvorakova, M.
    Vanek, T.
    MEDCHEMCOMM, 2016, 7 (12) : 2217 - 2231
  • [38] Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
    Wawruszak, Anna
    Kalafut, Joanna
    Okon, Estera
    Czapinski, Jakub
    Halasa, Marta
    Przybyszewska, Alicja
    Miziak, Paulina
    Okla, Karolina
    Rivero-Muller, Adolfo
    Stepulak, Andrzej
    CANCERS, 2019, 11 (02):
  • [39] Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: Synthesis and antiproliferative evaluation
    Bouchain, G
    Delorme, D
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (22) : 2359 - 2372
  • [40] New Benzothiazole/thiazole-Containing Hydroxamic Acids as Potent Histone Deacetylase Inhibitors and Antitumor Agents
    Truong Thanh Tung
    Dao Thi Kim Oanh
    Phan Thi Phuong Dung
    Van Thi My Hue
    Park, Sang Ho
    Han, Byung Woo
    Kim, Youngsoo
    Hong, Jin-Tae
    Han, Sang-Bae
    Nguyen-Hai Nam
    MEDICINAL CHEMISTRY, 2013, 9 (08) : 1051 - 1057
12345